Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ballinari

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|November 15, 1985
DBA/2-like minor histocompatibility antigens on a BALB/c lymphoma. A BALB/c anti-DBA/2 serum which lyses the tumor and blocks BALB/c anti-tumor and anti-DBA/2 effectorsD Ballinari, L Grazioli, M L Sensi, et al.
International Journal of Cancer|October 15, 1990
Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) lineL Rivoltini, M P Colombo, R Supino, et al.
British Journal of Cancer|March 31, 1999
Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastasesL Quintieri, A Rosato, N Amboldi, et al.
Cancer Research|January 1, 1991
Selective DNA interaction of the novel distamycin derivative FCE 24517M Broggini, E Erba, M Ponti, et al.
Cell Motility and the Cytoskeleton|January 1, 1990
Ultrastructural cytoskeleton alterations and modification of actin expression in the NIH/3T3 cell line after transformation with Ha-ras-activated oncogeneL Lombardi, D Ballinari, I Bongarzone, et al.
Journal of Immunogenetics|August 1, 1982
Biochemical analysis of a public H-2 specificity revealed by an anomalous reaction of an alloantiserum with a chemically induced C57BL/10 fibrosarcomaD Ballinari, M A Pierotti, L Grazioli, et al.
Haematologica|June 1, 1991
[New anthracyclines and multidrug resistance]M Grandi, D Ballinari, L Capolongo, et al.
Cancer Research|February 15, 1994
Adoptive transfer of lymphokine-activated killer cells loaded with 4'-deoxy-4'-iododoxorubicin: therapeutic effect in mice bearing lung metastasesS Mandruzzato, A Rosato, V Bronte, et al.
Immunology|August 1, 1988
Early lymphocyte activation molecule defined by the monoclonal antibody MLR-3: biochemical and functional studiesD Delia, C Traversari, D Ballinari, et al.
The Journal of General Virology|November 1, 1988
Characterization of papillomavirus polypeptides from bovine cutaneous fibropapillomasG Della Torre, M Muttini, D Ballinari, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|November 15, 1985
DBA/2-like minor histocompatibility antigens on a BALB/c lymphoma. A BALB/c anti-DBA/2 serum which lyses the tumor and blocks BALB/c anti-tumor and anti-DBA/2 effectorsD Ballinari, L Grazioli, M L Sensi, et al.
International Journal of Cancer|October 15, 1990
Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) lineL Rivoltini, M P Colombo, R Supino, et al.
British Journal of Cancer|March 31, 1999
Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastasesL Quintieri, A Rosato, N Amboldi, et al.
Cancer Research|January 1, 1991
Selective DNA interaction of the novel distamycin derivative FCE 24517M Broggini, E Erba, M Ponti, et al.
Cell Motility and the Cytoskeleton|January 1, 1990
Ultrastructural cytoskeleton alterations and modification of actin expression in the NIH/3T3 cell line after transformation with Ha-ras-activated oncogeneL Lombardi, D Ballinari, I Bongarzone, et al.
Journal of Immunogenetics|August 1, 1982
Biochemical analysis of a public H-2 specificity revealed by an anomalous reaction of an alloantiserum with a chemically induced C57BL/10 fibrosarcomaD Ballinari, M A Pierotti, L Grazioli, et al.
Haematologica|June 1, 1991
[New anthracyclines and multidrug resistance]M Grandi, D Ballinari, L Capolongo, et al.
Cancer Research|February 15, 1994
Adoptive transfer of lymphokine-activated killer cells loaded with 4'-deoxy-4'-iododoxorubicin: therapeutic effect in mice bearing lung metastasesS Mandruzzato, A Rosato, V Bronte, et al.
Immunology|August 1, 1988
Early lymphocyte activation molecule defined by the monoclonal antibody MLR-3: biochemical and functional studiesD Delia, C Traversari, D Ballinari, et al.
The Journal of General Virology|November 1, 1988
Characterization of papillomavirus polypeptides from bovine cutaneous fibropapillomasG Della Torre, M Muttini, D Ballinari, et al.
Pageof 4